Funding for this research was provided by:
Saolta hospital Group
Received: 3 May 2020
Accepted: 8 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: The study was approved by the Galway University Hospitals’ Central Research Ethics Committee in December 2017 (ref CA 1900). All participants provided written informed consent to participate in the study.
: Not applicable.
: R. Abdalgawad, M.F. Rafey, C. Murphy, I. Ioana, E. Slattery and P. O’Shea declare that they have no competing interests. C. Davenport, D. O’Keeffe and F.M. Finucane have received honoraria, travel grants and have served on advisory boards for Novo Nordisk, Eli Lilly, Ethicon, Pfizer Inc., Sanofi-Aventis, Astra Zeneca, Merck-Serono, Boehringer Ingelheim, Janssen and Novartis.